Matrixx Initiatives, Inc. is a consumer healthcare company engaged in the development and marketing of products which utilize unique delivery systems to provide consumers with "better ways to feel better." Zicam, LLC, our wholly-owned subsidiary, produces, markets, and sells a full line of Zicam® branded products. Zicam Cold Remedy assortment of cold shortening products is the heart of the Zicam line of respiratory products. From the introduction of our first Zicam Cold Remedy in 1999, we have continuously developed and introduced Zicam cold shortening and symptom-relieving products to the $6 billion cough/cold/allergy/sinus category. Each of our products delivers an enhanced consumer experience or unique approach to respiratory ailments. Matrixx's ability to bring new products to market quickly, access and support distribution at retail, and engage the consumer with clear and compelling communication has enabled the company’s success and continued development of the Zicam brand with American consumers. Our innovative and convenient products help improve the lives of busy people who don't have time to be sidelined by illness.

In early 2011, Matrixx was acquired by an investor group led by HIG Capital. The company’s headquarters are located in Bridgewater, New Jersey.